Moran Wealth Management LLC Acquires 21,334 Shares of Fresenius Medical Care AG (NYSE:FMS)

Moran Wealth Management LLC grew its holdings in Fresenius Medical Care AG (NYSE:FMS) by 9.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 254,710 shares of the company’s stock after acquiring an additional 21,334 shares during the quarter. Moran Wealth Management LLC’s holdings in Fresenius Medical Care were worth $5,767,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of FMS. Smartleaf Asset Management LLC increased its holdings in shares of Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company’s stock worth $28,000 after acquiring an additional 806 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Fresenius Medical Care in the third quarter worth about $38,000. Jones Financial Companies Lllp increased its holdings in shares of Fresenius Medical Care by 80.5% in the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company’s stock worth $102,000 after acquiring an additional 2,012 shares in the last quarter. Venturi Wealth Management LLC increased its holdings in shares of Fresenius Medical Care by 1,045.8% in the third quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company’s stock worth $112,000 after acquiring an additional 4,800 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Fresenius Medical Care by 43.3% during the fourth quarter. GAMMA Investing LLC now owns 7,164 shares of the company’s stock worth $162,000 after buying an additional 2,166 shares during the period. 8.37% of the stock is currently owned by institutional investors.

Fresenius Medical Care Stock Down 1.0 %

FMS stock opened at $23.75 on Tuesday. The business has a 50-day moving average of $23.55 and a 200-day moving average of $22.08. Fresenius Medical Care AG has a fifty-two week low of $17.93 and a fifty-two week high of $25.25. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The stock has a market capitalization of $13.93 billion, a P/E ratio of 19.62, a P/E/G ratio of 0.76 and a beta of 0.99.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. StockNews.com raised Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th. Truist Financial upped their price objective on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Finally, Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.